Aldeyra Therapeutics, Inc.
COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
Last updated:
Abstract:
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
Status:
Application
Type:
Utility
Filling date:
1 Feb 2021
Issue date:
2 Sep 2021